Jim Cramer on CNBC's Halftime Report.
Scott Mlyn | CNBC
Shares of Merck, soaring on encouraging trial data on the drugmaker's new Covid pill, could "conceivably go higher," CNBC's Jim Cramer said Friday.
'It is a game changer' — Cramer says Merck's new Covid pill could send stock even higher
Jim Cramer on CNBC's Halftime Report.
Scott Mlyn | CNBC
Shares of Merck, soaring on encouraging trial data on the drugmaker's new Covid pill, could "conceivably go higher," CNBC's Jim Cramer said Friday.
